# SHB

## Overview
The SHB gene encodes the SH2 domain containing adaptor protein B, a critical component in cellular signaling pathways. This adaptor protein is characterized by its structural domains, including an N-terminal region with proline-rich motifs, a central phosphotyrosine-binding (PTB) domain, and a C-terminal SH2 domain, which facilitate its interactions with phosphorylated tyrosine residues on various receptors (Cross2002The; Kriz2003The). As a scaffold protein, SHB plays a pivotal role in signal transduction, influencing processes such as cell survival, differentiation, and proliferation. It is involved in the regulation of immune responses, angiogenesis, and hematopoietic stem cell maintenance through its interactions with receptor tyrosine kinases and other signaling molecules (Gustafsson2013The; Anneren2003The). The clinical significance of SHB is underscored by its altered expression in various cancers, including acute myeloid leukemia and melanoma, where it impacts disease progression and patient prognosis (Zang2015Vascular; Jamalpour2017Tumor).

## Structure
The SHB protein is an adaptor protein characterized by several structural features that facilitate its role in signal transduction. It contains an N-terminal region with proline-rich motifs, a central phosphotyrosine-binding (PTB) domain, and a C-terminal SH2 domain (Cross2002The; Kriz2003The). These domains enable SHB to interact with phosphorylated tyrosine residues on various receptors, such as the fibroblast growth factor receptor 1 (FGFR-1) and the platelet-derived growth factor (PDGF) receptors (Cross2002The; Kriz2003The).

The SH2 domain is crucial for binding to specific phosphorylated tyrosines, such as tyrosine 766 in FGFR-1, which is essential for activating downstream signaling pathways like the Ras/MEK/MAPK cascade (Cross2002The). The proline-rich motifs in the N-terminal region allow interactions with SH3 domain-containing proteins, contributing to the formation of signaling complexes (Cross2002The).

SHB undergoes post-translational modifications, including phosphorylation at specific tyrosine residues, which are important for its interactions and function in signaling pathways (Wagner2020The). The protein may also exist in different splice variant isoforms, which can affect its functional interactions and roles in cellular processes (Kriz2003The).

## Function
The SHB gene encodes an SH2 domain-containing adaptor protein that plays a significant role in various cellular processes, including signal transduction pathways. SHB is involved in the regulation of cell survival, differentiation, and proliferation by forming signaling complexes in response to receptor tyrosine kinase activation. It interacts with multiple receptors, such as the platelet-derived growth factor (PDGF) receptor, fibroblast growth factor (FGF) receptor, and neural growth factor (NGF) receptor TRKA, among others (Anneren2003The).

In T cells, SHB is crucial for T cell receptor (TCR) signaling, where it forms multiprotein complexes that activate pathways like JNK, ERK, and Ca2+, leading to interleukin-2 (IL-2) production. This interaction is essential for proper immune responses and cellular homeostasis (Anneren2003The). In endothelial cells, SHB is involved in angiogenic and anti-angiogenic processes, promoting cell spreading, migration, and tubular morphogenesis through focal adhesion kinase (FAK) activation (Anneren2003The).

SHB also plays a role in hematopoietic stem cells (HSCs), where it regulates cell cycle progression by modulating FAK activity. This regulation is crucial for the proliferation and maintenance of long-term hematopoietic stem cells (LT-HSCs) (Gustafsson2013The). In the context of Eph receptor signaling, SHB facilitates cell segregation and boundary formation by interacting with proteins like Nck, RasGAP, and Chimaerins, which are involved in cytoskeletal rearrangement and cell mobility (Wagner2020The).

## Clinical Significance
Alterations in the expression of the SHB gene have significant clinical implications, particularly in the context of acute myeloid leukemia (AML). Studies have shown that while SHB gene mutations are rare in AML, altered SHB expression levels are associated with disease characteristics and patient prognosis. High SHB mRNA expression is linked to poorer survival outcomes, whereas lower expression correlates with increased overall survival in AML patients. This suggests that SHB expression levels could serve as a prognostic marker in AML (Jamalpour2017Tumor).

In acute promyelocytic leukemia (APL), characterized by the PML-RARA translocation, a significant reduction in SHB mRNA levels is observed, which is associated with a favorable prognosis. SHB knockdown in leukemic cell lines results in reduced cell proliferation, indicating that SHB expression is crucial for leukemic cell growth (Jamalpour2017Tumor).

Beyond leukemia, SHB gene alterations have been implicated in melanoma metastasis. In Shb-deficient mice, increased vascular permeability and reduced pericyte coverage lead to enhanced tumor metastasis, suggesting that SHB plays a role in tumor angiogenesis and immune response modulation (Zang2015Vascular). These findings highlight the potential of targeting SHB expression or function in therapeutic strategies for cancer.

## Interactions
The SHB protein, also known as SH2 domain containing adaptor protein B, is involved in various protein interactions that play critical roles in cellular signaling pathways. SHB acts as a scaffold protein in the signaling pathways of Eph receptors, particularly EphB2, which are essential for cell segregation and boundary formation. It interacts with several proteins, including the Nck adaptor protein, p120 RasGAP, and α- and β-chimaerins. These interactions are facilitated by the phosphorylation of specific tyrosine residues on SHB, namely Y246, Y297, and Y336, which serve as binding sites for these proteins (Wagner2020The).

SHB also interacts with the fibroblast growth factor receptor 1 (FGFR-1) by binding to tyrosine 766, which is crucial for the activation of the Ras/MEK/MAPK signaling pathway. This interaction is mediated through the SH2 domain of SHB and is necessary for the phosphorylation of FRS2, a docking protein that links FGFR-1 to the Ras/MEK/MAPK pathway (Cross2002The).

Additionally, SHB is involved in interactions with the Epstein-Barr virus-encoded Latent Membrane Protein 2A (LMP2A) and intersectin 1 (ITSN1), where it mediates the phosphorylation of ITSN1 and SHB adaptors by tyrosine kinases (Dergai2013The).


## References


[1. (Dergai2013The) Oleksandr Dergai, Mykola Dergai, Inessa Skrypkina, Liudmila Matskova, Liudmyla Tsyba, Daria Gudkova, and Alla Rynditch. The lmp2a protein of epstein–barr virus regulates phosphorylation of itsn1 and shb adaptors by tyrosine kinases. Cellular Signalling, 25(1):33–40, January 2013. URL: http://dx.doi.org/10.1016/j.cellsig.2012.09.011, doi:10.1016/j.cellsig.2012.09.011. This article has 19 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.cellsig.2012.09.011)

[2. (Gustafsson2013The) Karin Gustafsson, Garrett Heffner, Pamela L. Wenzel, Matthew Curran, Jan Grawé, Shannon L. McKinney-Freeman, George Q. Daley, and Michael Welsh. The src homology 2 protein shb promotes cell cycle progression in murine hematopoietic stem cells by regulation of focal adhesion kinase activity. Experimental Cell Research, 319(12):1852–1864, July 2013. URL: http://dx.doi.org/10.1016/j.yexcr.2013.03.020, doi:10.1016/j.yexcr.2013.03.020. This article has 11 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.yexcr.2013.03.020)

[3. (Cross2002The) Michael J. Cross, Lingge Lu, Peetra Magnusson, Daniel Nyqvist, Kristina Holmqvist, Michael Welsh, and Lena Claesson-Welsh. The shb adaptor protein binds to tyrosine 766 in the fgfr-1 and regulates the ras/mek/mapk pathway via frs2 phosphorylation in endothelial cells. Molecular Biology of the Cell, 13(8):2881–2893, August 2002. URL: http://dx.doi.org/10.1091/mbc.e02-02-0103, doi:10.1091/mbc.e02-02-0103. This article has 72 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1091/mbc.e02-02-0103)

[4. (Wagner2020The) Melany J. Wagner, Marilyn S. Hsiung, Gerald D. Gish, Rick D. Bagshaw, Sasha A. Doodnauth, Mohamed A. Soliman, Claus Jørgensen, Monika Tucholska, and Robert Rottapel. The shb scaffold binds the nck adaptor protein, p120 rasgap, and chimaerins and thereby facilitates heterotypic cell segregation by the receptor ephb2. Journal of Biological Chemistry, 295(12):3932–3944, March 2020. URL: http://dx.doi.org/10.1074/jbc.ra119.009276, doi:10.1074/jbc.ra119.009276. This article has 7 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.ra119.009276)

[5. (Anneren2003The) Cecilia Anneren, Cecilia Lindholm, Vitezslav Kriz, and Michael Welsh. The frk / rak-shb signaling cascade: a versatile signal- transduction pathway that regulates cell survival, differentiation and proliferation. Current Molecular Medicine, 3(4):313–324, June 2003. URL: http://dx.doi.org/10.2174/1566524033479744, doi:10.2174/1566524033479744. This article has 60 citations and is from a peer-reviewed journal.](https://doi.org/10.2174/1566524033479744)

[6. (Jamalpour2017Tumor) Maria Jamalpour, Xiujuan Li, Lucia Cavelier, Karin Gustafsson, Gustavo Mostoslavsky, Martin Höglund, and Michael Welsh. Tumor shb gene expression affects disease characteristics in human acute myeloid leukemia. Tumor Biology, 39(10):101042831772064, October 2017. URL: http://dx.doi.org/10.1177/1010428317720643, doi:10.1177/1010428317720643. This article has 7 citations and is from a peer-reviewed journal.](https://doi.org/10.1177/1010428317720643)

[7. (Zang2015Vascular) Guangxiang Zang, Karin Gustafsson, Maria Jamalpour, JongWook Hong, Guillem Genové, and Michael Welsh. Vascular dysfunction and increased metastasis of b16f10 melanomas in shb deficient mice as compared with their wild type counterparts. BMC Cancer, April 2015. URL: http://dx.doi.org/10.1186/s12885-015-1269-y, doi:10.1186/s12885-015-1269-y. This article has 19 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s12885-015-1269-y)

[8. (Kriz2003The) Vitezslav Kriz, Cecilia Annerén, Cheng Lai, Jacob Karlsson, Jaroslav Mares, and Michael Welsh. The shb adapter protein is required for efficient multilineage differentiation of mouse embryonic stem cells. Experimental Cell Research, 286(1):40–56, May 2003. URL: http://dx.doi.org/10.1016/s0014-4827(03)00099-5, doi:10.1016/s0014-4827(03)00099-5. This article has 12 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/s0014-4827(03)00099-5)